Humanoid Secures $152M Series A Led by Prime Movers Lab, Bosch to Scale Production
London-based robotics startup Humanoid has successfully raised $152 million in a Series A funding round, propelling its valuation to over $1 billion. The round was spearheaded by Prime Movers Lab, a venture firm notable for its involvement with Figure AI, which achieved a $39 billion valuation. Other significant investors participating in this funding round include Bosch, Schaeffler, Aglaé Ventures (the investment arm of LVMH chairman Bernard Arnault), and Taiwan's Fubon Financial. A key aspect of this investment is the strategic partnership with Bosch, which is set to manufacture Humanoid's wheeled robots at scale. This collaboration aims to accelerate the production and deployment of Humanoid's technology in the market. The substantial capital infusion and manufacturing agreement signal strong confidence in Humanoid's potential to disrupt the robotics industry.
This significant Series A funding round for Humanoid, coupled with Bosch's commitment to scaled manufacturing, highlights a strategic pivot in the robotics sector towards practical, deployable solutions. The substantial investment, exceeding $1 billion in valuation, suggests investor confidence in Humanoid's technology and market strategy, particularly its focus on wheeled robots which may offer a more immediate path to commercialization compared to legged humanoid robots. The involvement of established industrial players like Bosch indicates a maturing ecosystem where startups are increasingly leveraging established manufacturing capabilities to accelerate market penetration. This approach could mitigate production bottlenecks and reduce time-to-market, positioning Humanoid to capitalize on growing demand for automation across various industries. The next decade will likely see a greater emphasis on such pragmatic collaborations, bridging the gap between advanced robotics research and widespread industrial adoption.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.